March 7, 2024
FREMONT, Calif. -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot facility in Wuxi, China. This strategic move increases the company's manufacturing capacity to meet the growing worldwide demand for comprehensive cell analysis solutions. The Wuxi facility offers the advantage of fostering unique vendor [...]
Tom O’Lenic joins RedShiftBio as Chief Executive Officer
March 7, 2024
BOXBOROUGH MA. --RedShiftBioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for the measurement of protein characterization and protein concentration used in biotherapeutic drug development and manufacturing, proudly announces the appointment of Tom O’Lenic as its new Chief Executive Officer (CEO). With over two decades of experience in commercial leadership and management roles, O’Lenic brings [...]
March 6, 2024
WALTHAM, Mass. -- NanoMosaic, the multiplex and multi-omic quantification company, today announced the expanded capabilities and availability of assays optimized on its Tessie™ system for use in gene therapy applications. The platform combines the ability to quantify proteins and nucleic acids in a single run, enabling the simultaneous detection and characterization of adeno-associated virus (AAV) [...]
SOPHiA GENETICS Announces New Customer in Costa Rica
March 6, 2024
Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Universidad de Costa Rica El Centro de Investigación en Cirugía y Cáncer (CICICA) is now live on the SOPHiA DDM™ [...]
March 5, 2024
Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers. BOULDER, CO InDevR Inc., a global leader in vaccine testing and multiplexed assay development for vaccine manufacturers, is excited to announce the launch of OmniFlu HA, a validated, off-the-shelf kit for seasonal influenza vaccine [...]
INDUTRADE ACQUIRES THE NORWEGIAN LABORATORY TECHNOLOGY COMPANY MATRIKS
March 5, 2024
Indutrade has signed an agreement to acquire all shares in the Norwegian company Matriks AS, www.matriks.no, with annual sales of approximately NOK 215 million (SEK 205 million). Matriks is a technical trading company specialised on analysis instruments, systems and consumables for chemical and biochemical laboratories. The company offers a wide range of products within liquid- [...]
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
March 5, 2024
Precision Dx Products are CE-marked and compliant with EU IVDR 2017/746 regulations Precision Dx Products include Twist Precision Prep and Enrichment Dx Kit, Twist Precision Exome Dx Panel and Twist Precision Exome Dx Kit SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality [...]
LabWare Opens Korean Office LabWare,한국 사무소 개소
March 5, 2024
SEOUL, KOREA -- LabWare Korea Co., Ltd LabWare is excited to announce the grand opening of our latest office, situated in the heart of Seoul, Korea. LabWare는 대한민국 서울에 새로운 사무실의 개소를 알리게 되어 매우 기쁘게 생각합니다. This expansion marks a significant stride forward in our global objective to provide world-leading, cutting-edge laboratory informatics solutions [...]
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production
March 5, 2024
IRVINE, Calif. -- In a groundbreaking development, Zymo Research, a leader in biotechnology innovation, has revolutionized large-scale production of animal-free recombinant RNase A (PureRec RNase A), a challenge that persisted for over half a century. This breakthrough will enable the widespread use of recombinant RNase A in applications where an animal-free enzyme is preferred. RNase [...]
Phenomenex Introduces Biozen dSEC-7, A New Way to Study AAVs with Unprecedented Speed and Efficiency
March 5, 2024
The Latest Breakthrough in Gene Therapy Aggregate Analysis TORRANCE, CA, Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, proudly announces its newest Size Exclusion Chromatography (SEC) product, Biozen dSEC-7, for the analysis of AAVs (adeno-associated viral vectors). In the emerging field of gene therapy, modified DNA [...]

